Lord, Abbett & Co. LLC Neuronetics, Inc. Transaction History

Lord, Abbett & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $230,290 - $526,867	-57,144 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.31 - $13.03 $5.2 Million - $8.15 Million	-625,840 Reduced 91.63%	57,144 $475,000
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $2.38 Million - $4.55 Million	264,568 Added 63.23%	682,984 $8.54 Million
Q1 2019 May 15, 2019	SELL	$13.6 - $19.58 $130,437 - $187,791	-9,591 Reduced 2.24%	418,416 $6.38 Million
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $166,624 - $331,581	10,414 Added 2.49%	428,007 $8.28 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $4.56 Million - $7.04 Million	187,593 Added 81.56%	417,593 $13.4 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $6.12 Million - $6.39 Million	230,000 New	230,000 $6.12 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $46.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.